Skip to main content
. 2016 Aug 23;8(13):20679–20694. doi: 10.18632/oncotarget.11557

Figure 6. Survival analysis of patients with BC expressing genes risk-associated pathways in the tumor.

Figure 6

The blue curve represents the survival time of patients with BC not exhibiting changes in the 25 risk-associated genes. The red curve represents survival time of patients exhibiting changes in at least one of these genes. A P value of 0.02 indicates that a gene may serve as a biomarker to assess the risk of recurrence and survival time.